The ability to probe the smallest building blocks of matter has long fascinated scientists, fueling advancements in medicine, ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Three sectors stand out for their exceptional potential: defense, energy, and pharmaceuticals. This momentum is represented in the pharmaceutical industry, where research laboratories still buy ...

Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...

Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

I’m perfectly happy for the wizards to help me out in drug development and help speed medicines to […] the right patients,” he said. Oncology researcher Pierce works at Owkin, a Paris-based ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...